Advanced Search
Zhang DaXin, . The Influence of Different Fractionated Irradiation Conc-omitant with Chemotherapy on Human lung Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 1997, 24(3): 160-162.
Citation: Zhang DaXin, . The Influence of Different Fractionated Irradiation Conc-omitant with Chemotherapy on Human lung Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 1997, 24(3): 160-162.

The Influence of Different Fractionated Irradiation Conc-omitant with Chemotherapy on Human lung Adenocarcinoma

More Information
  • 1. Marvin,Z.Rotman.Chemoirradiation.A New Initia-rive In Cancer Treatment Radiology,1992,184(2),319.
    2. L.pewit.Combined Treatment of Radiation and Cis-iamminedichloroplatinum: A Review of Experiment and Clinical Data.Int.J.Radia.Oncol.Biol.Phys>1987,13(3):403.
    3. David.A.pecker,Anibal Drelichman.John.Jacobs,et al.Adjuvant Chemotherapy With Cis-Diammin-odichloroplatinum and 120-Hour Infusion Fluorouacilin Stag 3 and 4 Squamous Cell Carcinoma of the headand Neck.Cancer,1983,51: 1353.
    4. 将国梁,王丽娟,傅申,等.每日两次分割放射治疗非小细胞肺您远期疗效分析.中华放射肿瘤学杂志,1993,2(4):231.
    5. 张小建.何少琴,冯炎,等.鬼臼唾盼贰对人肺腺癌细胞放射效应的影响.中华放射肿瘤学杂志,1993,2(4) :252.
  • Related Articles

    [1]WANG Jingyi, ZHONG Yuling, WU Lin. Immunotherapy for Advanced Non-small Cell Lung Cancer: Research Progress and Perspectives[J]. Cancer Research on Prevention and Treatment, 2024, 51(6): 409-418. DOI: 10.3971/j.issn.1000-8578.2024.24.0090
    [2]SU Chunxia, YU Xin. Advances of Immunotherapy for Non-small Cell Lung Cancer with Driver Gene Mutations[J]. Cancer Research on Prevention and Treatment, 2023, 50(1): 1-5. DOI: 10.3971/j.issn.1000-8578.2023.22.1033
    [3]CHENG Ying. Research Progress of Immunotherapy for Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2021, 48(8): 745-750. DOI: 10.3971/j.issn.1000-8578.2021.21.0472
    [4]LI Xiangmin, FAN Zaiwen. Challenges of Immune Checkpoint Inhibitors in Treatment of Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2019, 46(6): 556-560. DOI: 10.3971/j.issn.1000-8578.2019.18.1563
    [5]WU Li, WANG Yongsheng. Progress in Vaccines Against Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2016, 43(8): 721-727. DOI: 10.3971/j.issn.1000-8578.2016.08.015
    [6]LI Xiaofen, YUAN Ying. Individualized Treatment for Advanced Colorectal Cancer Patients Based on Molecular Characteristics[J]. Cancer Research on Prevention and Treatment, 2015, 42(09): 924-928. DOI: 10.3971/j.issn.1000-8578.2015.09.014
    [7]Liu Mingyue, Hou Guiqin, Gao Tianhui, Cui Yao, Li Xiaoyan, Zhou Yun. Efficacy of Pemetrexed Chemotherapy in Advanced Non-small Cell Lung Cancer with EGFR-TKI Resistence[J]. Cancer Research on Prevention and Treatment, 2012, 39(06): 713-715. DOI: 10.3971/j.issn.1000-8578.2012.06.025
    [8]ZHAN Yong-zi, HUANG Chang-jie, HUANG Jian-feng. Clinical Observation of Erlotinib in Treatment of Patients with Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2010, 37(04): 461-462. DOI: 10.3971/j.issn.1000-8578.2010.04.025
    [9]LI Jing, LI Xin-qun, LI Jia-bang, et al, . Clinical Observations of Advanced Non-Small-Cell Lung Cancer Patients Treated with Continuous Infusion of Cisplatin and Oral Etoposide[J]. Cancer Research on Prevention and Treatment, 2000, 27(02): 144-145. DOI: 10.3971/j.issn.1000-8578.338
    [10]Liu Pu-xiang, . Short-term Effect of DDP-based combined chemotherapy in the treatment of advanced non-small cell lung cancer[J]. Cancer Research on Prevention and Treatment, 1995, 22(4): 247-248,246.

Catalog

    Article views (1012) PDF downloads (201) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return